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Aims: To compare the prognostic value of pharmacologic stress echocardiography in diabetic and 
nondiabetic patients with chest pain and intermediate-to-high threshold positive exercise 
electrocardiography.  
Materials and methods: 935 chest pain patients (131 diabetics) with ST-segment depression  ≥1 
mm on exercise electrocardiography at >75 watt workload underwent dipyridamole (n=786) or 
dobutamine (n=149) stress echocardiography and were followed-up for the occurence of hard 
(death, infarction) and major events (death, infarction, late revascularization).  
Results: During a median follow-up of 26 months, 158 events (51 deaths, 28 myocardial 
infarctions, and 79 late revascularizations) occurred: 34 in diabetics and 124 in nondiabetics (see 
Figure). Independent predictors of hard events were age, diabetes, and ischemia at stress echo. 5-
year hard event rate was 24 % in patients with and 4 % in those without ischemia (p<0.0001). 
Independent predictors of major events were age, diabetes, hypercholesterolemia, smoking habit, 
antianginal therapy at the time of testing, and ischemia at stress echo. 5-year major event rate was 
46 % in patients with and 7 % in those without ischemia (p<0.0001).  
Conclusions: Stress echocardiography is effective in risk stratifying diabetics and nondiabetics 
with intermediate-to-high threshold ischemic exercise electrocardiography. However, major event 
rate associated with a non ischemic test is similar in diabetics and nondiabetics during the first year 
of follow-up, and markedly increased in the former thereafter. 
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